Statins Diversity Revealed by the Deep-Sea-Derived Fungus <i>Penicillium viridicatum</i>

Seven new (<b>1</b>–<b>7</b>) and six known (<b>8</b>–<b>13</b>) statin derivatives were obtained from the deep-sea-derived fungus <i>Penicillium viridicatum</i> MCCC 3A00265. The structures assigned to the new compounds were based on a com...

Full description

Saved in:
Bibliographic Details
Main Authors: Meng Zhang, Rong Chao, Jia-Jian Wang, Zi-Han Xu, Ji-Hong Zhang, Da-Li Meng, Tai-Zong Wu, Xian-Wen Yang
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/23/2/87
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Seven new (<b>1</b>–<b>7</b>) and six known (<b>8</b>–<b>13</b>) statin derivatives were obtained from the deep-sea-derived fungus <i>Penicillium viridicatum</i> MCCC 3A00265. The structures assigned to the new compounds were based on a comprehensive analysis of the spectroscopic data, with absolute configurations established by Mosher analysis and biogenetic consideration. Most of the new compounds (<b>1</b>–<b>5</b> and <b>7</b>) share an octohydronaphthalene backbone, except that viridecalin F (<b>6</b>) possesses an uncommon naphthalene core. Viridecalins C (<b>3</b>) and F (<b>6</b>) and the two known compounds <b>9</b> and <b>11</b> exhibit considerable ability in reactivating mutant p53 protein at 10 μM, while viridecalin C showcases the most potent reactivation activity, indicating the potential of application in cancer therapy.
ISSN:1660-3397